Percutaneous coronary intervention: historical perspectives, current status, and future directions.

[1]  G. Stone,et al.  Randomized Comparison of Distal Protection With a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts , 2003, Circulation.

[2]  S. Goldberg,et al.  Current status of percutaneous coronary intervention: Results from a large international trial , 2003 .

[3]  S. Steinhubl,et al.  Clinical Implications of Percutaneous Coronary Intervention-Clopidogrel in Unstable angina to prevent Recurrent Events (PCI-CURE) Study: A US Perspective , 2002, Circulation.

[4]  P. Serruys,et al.  Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): Sirolimus-Eluting Stents Inhibit Restenosis Irrespective of the Vessel Size , 2002, Circulation.

[5]  E. Topol,et al.  Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study , 2002, The Lancet.

[6]  P. Serruys,et al.  Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[7]  M. Nobuyoshi,et al.  Long-Term Clinical and Angiographic Follow-Up After Coronary Stent Placement in Native Coronary Arteries , 2002, Circulation.

[8]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[9]  J. J. Griffin,et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.

[10]  M. Leon,et al.  Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts , 2002, Circulation.

[11]  P. Teirstein,et al.  Prolonged antiplatelet therapy and reduced stenting eliminates late thrombosis after radiation: the SCRIPPS III trial , 2002 .

[12]  P. Serruys,et al.  210-Day follow-up of the RAVEL study: a randomized study with the sirolimus-eluting Bx VELOCITY™ balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions , 2002 .

[13]  P. Serruys,et al.  Late (two-year) follow-up from the First-In-Man (FIM) experience after implantation of sirolimus-eluting stents , 2002 .

[14]  P. Serruys,et al.  Sirolimus-eluting stents abolish neointimal hyperplasia in patients with in-stent restenosis: late angiographic and intravascular ultrasound results , 2002 .

[15]  Jerome Sacks,et al.  Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. , 2002, Journal of the American College of Cardiology.

[16]  L. Khachigian,et al.  Coronary in-stent restenosis: current status and future strategies. , 2002, Journal of the American College of Cardiology.

[17]  S. Fichtlscherer,et al.  Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. , 2001, Journal of the American College of Cardiology.

[18]  F. Eberli,et al.  Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. , 2001, The New England journal of medicine.

[19]  A. Kastrati,et al.  Stenting for small coronary vessels: a contestable winner. , 2001, Journal of the American College of Cardiology.

[20]  B. Rutherford,et al.  Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. , 2001, Indian heart journal.

[21]  P. Serruys,et al.  Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Study (ARTS) Trial , 2001, Circulation.

[22]  P. Serruys,et al.  Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients , 2001 .

[23]  C. Di Mario,et al.  Cerebral Protection With Filter Devices During Carotid Artery Stenting , 2001, Circulation.

[24]  K. Kent,et al.  Clinical utility of the cutting balloon. , 2001, The Journal of invasive cardiology.

[25]  Mitchell W. Krucoff,et al.  Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th , 2001, Journal of the American College of Cardiology.

[26]  M. Morice,et al.  Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. , 2001, The New England journal of medicine.

[27]  A. Kastrati,et al.  Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen. , 2001, Journal of the American College of Cardiology.

[28]  I. Henry,et al.  Protected Renal Stenting with the PercuSurge GuardWire Device: A Pilot Study , 2001, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[29]  V. Hasselblad,et al.  Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. , 2001, JAMA.

[30]  D. Baim,et al.  Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials , 2001, Circulation.

[31]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[32]  P. Teirstein,et al.  Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. , 2001, The New England journal of medicine.

[33]  Jeffrey J. Popma,et al.  Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study , 2001, Circulation.

[34]  A. Jacobs,et al.  Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986: The National Heart, Lung, and Blood Institute Registries , 2000, Circulation.

[35]  R. Califf,et al.  Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial. , 2000, Journal of the American College of Cardiology.

[36]  T. Meinertz,et al.  Treatment of Aortocoronary Vein Graft Lesions With Membrane-Covered Stents: A Multicenter Surveillance Trial , 2000, Circulation.

[37]  D. Holmes,et al.  Coronary artery stents. , 2000, JAMA.

[38]  M. Schwaiger,et al.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. , 2000, The New England journal of medicine.

[39]  M. Bertrand,et al.  Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study (CLASSICS). , 2000, Circulation.

[40]  M. Leon,et al.  Intracoronary β-Radiation Therapy Inhibits Recurrence of In-Stent Restenosis , 2000 .

[41]  R. Califf,et al.  Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. , 2000, Journal of the American College of Cardiology.

[42]  Bari Investigators.  Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. , 2000, Journal of the American College of Cardiology.

[43]  David R. Holmes,et al.  Strategic Approaches in Coronary Intervention , 2000 .

[44]  Bruce R. Brodie,et al.  Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .

[45]  Raimund Erbel,et al.  Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis After Initial Balloon Angioplasty , 1999 .

[46]  K. Teo,et al.  Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). , 1999, Circulation.

[47]  A. Kastrati,et al.  Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. , 1998, Circulation.

[48]  P Serruys,et al.  Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. , 1998, The New England journal of medicine.

[49]  S. Pocock,et al.  A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting , 1998 .

[50]  M. Hadamitzky,et al.  Vessel size and long-term outcome after coronary stent placement. , 1998, Circulation.

[51]  Antonio Colombo,et al.  Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) , 1998, The Lancet.

[52]  T. Investigators.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.

[53]  E. Topol.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade , 1998, The Lancet.

[54]  E. Alderman.  Results from late-breaking clinical trials sessions at ACC '98. American College of Cardiology. , 1998, Journal of the American College of Cardiology.

[55]  D. Holmes,et al.  Rotational atherectomy for bifurcation lesions of the coronary circulation: technique and initial experience. , 1998, International journal of cardiology.

[56]  P. Fitzgerald,et al.  'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS). , 1998, Circulation.

[57]  P. Teirstein,et al.  Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. , 1997, Circulation.

[58]  M. Leon,et al.  Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone. , 1997, Circulation.

[59]  M. Leon,et al.  Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. , 1997, The New England journal of medicine.

[60]  C. Bauters,et al.  Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. , 1997, Circulation.

[61]  F. Schwarz,et al.  Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) Study. , 1997, Circulation.

[62]  C Di Mario,et al.  Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results. , 1997, Circulation.

[63]  M. Morice.  Stenting for small coronary vessels. , 1997, The Journal of invasive cardiology.

[64]  L Chiariello,et al.  A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. , 1997, The New England journal of medicine.

[65]  K. Endresen,et al.  Stenting in Chronic Coronary Occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. , 1996, Journal of the American College of Cardiology.

[66]  M. Savage,et al.  The interventional cardiologist and the diabetic patient. Have we pushed the envelope too far or not far enough? , 1996, Circulation.

[67]  A. Cribier,et al.  Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry. , 1996, Circulation.

[68]  F. Neumann,et al.  Platelet activation and coronary stent implantation. Effect of antithrombotic therapy. , 1996, Circulation.

[69]  M. Hadamitzky,et al.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. , 1996, The New England journal of medicine.

[70]  H Yokoi,et al.  Three-year follow-up after implantation of metallic coronary-artery stents. , 1996, The New England journal of medicine.

[71]  M. Savage,et al.  Coronary artery stents , 1995, The Lancet.

[72]  R. Califf,et al.  A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. , 1995, Circulation.

[73]  P Hall,et al.  Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. , 1995, Circulation.

[74]  S. Marx,et al.  Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. , 1995, Circulation research.

[75]  P. Teirstein,et al.  Long-term angiographic and clinical outcome after implantation of a ballon-expandable stent in the native coronary circulation☆ , 1994 .

[76]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[77]  E. Topol,et al.  Results of directional coronary atherectomy during multicenter preapproval testing. The US Directional Coronary Atherectomy Investigator Group. , 1993, The American journal of cardiology.

[78]  R. Califf,et al.  A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease , 1993 .

[79]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[80]  M. Leon,et al.  Emergent Use of Balloon‐Expandable Coronary Artery Stenting for Failed Percutaneous Transluminal Coronary Angioplasty , 1992, Circulation.

[81]  B Meier,et al.  Angiographic follow-up after placement of a self-expanding coronary-artery stent. , 1991, The New England journal of medicine.

[82]  J. O’Keefe,et al.  Left main coronary angioplasty: early and late results of 127 acute and elective procedures. , 1989, The American journal of cardiology.

[83]  U. Sigwart,et al.  Emergency stenting for acute occlusion after coronary balloon angioplasty. , 1988, Circulation.

[84]  F. Loop,et al.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Circulation.

[85]  F. Mohr,et al.  Role of laser and thermal ablation devices in the treatment of vascular diseases. , 1988, The American journal of cardiology.

[86]  K. Kent.  Restenosis after percutaneous transluminal coronary angioplasty. , 1988, The American journal of cardiology.

[87]  D. Faxon,et al.  Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. , 1988, The New England journal of medicine.

[88]  S. Ellis,et al.  In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8,207 procedures. , 1988, Journal of the American College of Cardiology.

[89]  F Joffre,et al.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. , 1987, The New England journal of medicine.

[90]  J. Douglas,et al.  In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. , 1985, Circulation.

[91]  L. Fisher,et al.  Comparison of operative mortality and morbidity for initial and repeat coronary artery bypass grafting: The Coronary Artery Surgery Study (CASS) registry experience. , 1984, The Annals of thoracic surgery.

[92]  R E Vlietstra,et al.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.

[93]  B. Meier,et al.  Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. , 1983, Journal of the American College of Cardiology.

[94]  W. Siegenthaler,et al.  Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.

[95]  A. Grüntzig.  TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSIS , 1978, The Lancet.

[96]  M. Lipton,et al.  The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. , 1976, Circulation.

[97]  Orchard Tj.  Letter: Mobile coronary care. , 1974 .

[98]  R. Favaloro,et al.  Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. , 1968, The Annals of thoracic surgery.

[99]  J. Dimarco.  Results from late-breaking clinical trials sessions at ACC 2001 , 2001 .

[100]  I. Palacios,et al.  Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. , 2001, Journal of the American College of Cardiology.

[101]  Seung‐Jung Park,et al.  Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes. , 1998, Journal of the American College of Cardiology.

[102]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[103]  S. Goldberg,et al.  PTCA following coronary bypass surgery. , 1988, Cardiovascular clinics.

[104]  R. Asinger,et al.  A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes. , 1984, The American journal of cardiology.